BG Medicine's Q1 Revenues Jump Sharply

An eight-fold increase in revenues was driven by a collaboration with Danish researchers to develop diagnostic biomarkers for heart attacks.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories